Sort by
Refine Your Search
-
Start Date: Immediately ---- Position Duration: Expected to Continue Until May 29, 2025 ---- Location: UT MAIN CAMPUS ---- Job Details: General Notes PhD must have been received within the past 3 years
-
: 40 ---- FLSA Status: Exempt ---- Earliest Start Date: Immediately ---- Position Duration: Expected to Continue Until May 23, 2025 ---- Location: UT MAIN CAMPUS ---- Job Details: Purpose We seek
-
Eligibility Verification: If hired, you will be required to complete the federal Employment Eligibility Verification I-9 form. You will be required to present acceptable and original documents to prove your
-
Status: Exempt ---- Earliest Start Date: Immediately ---- Position Duration: Expected to Continue Until Jun 14, 2025 ---- Location: UT MAIN CAMPUS ---- Job Details: Job Description Summary
-
: Exempt ---- Earliest Start Date: Jun 01, 2024 ---- Position Duration: Expected to Continue Until May 31, 2026 ---- Location: UT MAIN CAMPUS ---- Job Details: General Notes The Digital Heart Health Lab
-
Employment Eligibility Verification I-9 form. You will be required to present acceptable and original documents to prove your identity and authorization to work in the United States. Documents need to be
-
---- Earliest Start Date: Sep 01, 2024 ---- Position Duration: Expected to Continue Until Aug 31, 2026 ---- Location: UT MAIN CAMPUS ---- Job Details: General Notes The Postdoctoral Fellow program aims
-
---- Earliest Start Date: Sep 01, 2024 ---- Position Duration: Expected to Continue Until May 31, 2026 ---- Location: UT MAIN CAMPUS ---- Job Details: General Notes Dean Eun-Ok Im, is a pioneer and leader in
-
Status: Exempt ---- Earliest Start Date: Immediately ---- Position Duration: Expected to Continue Until Apr 30, 2025 ---- Location: UT MAIN CAMPUS ---- Job Details: General Notes Dr. Jordan Conwell at The
-
-mediated T-ALL support, with the goal of designing novel therapeutic strategies. The postdoctoral fellow will design and implement in vitro and in vivo assays using mouse models of T-ALL and primary patient